Skip to main content
Log in

HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough

  • UNM CLINICAL CASE CONFERENCES
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  Google Scholar 

  2. Trevisani F, Frigerio M, Santi V, et al. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis. 2010;42:341–347.

    Article  Google Scholar 

  3. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–687.

    Article  CAS  Google Scholar 

  4. Ray RB, Meyer K, Ray R. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology. 2000;271:197–204.

    Article  CAS  Google Scholar 

  5. El-Refaie A, Savage K, Bhattacharya S, et al. HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol. 1996;24:277–285.

    Article  CAS  Google Scholar 

  6. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004;127:S87–S96.

    Article  CAS  Google Scholar 

  7. Donato F, Tagger A, Chiesa R, et al. Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma: a case-control study in Italy—Brescia HCC study. Hepatology. 1997;26:579–584.

    Article  CAS  Google Scholar 

  8. Gaddikeri S, McNeeley MF, Wang CL, et al. Hepatocellular carcinoma in the noncirrhotic liver. Am J Roentgenol. 2014;203:W34–W47.

    Article  Google Scholar 

  9. Khanna R, Verma SK. Pediatric hepatocellular carcinoma. World J Gastroenterol. 2018;24:3980–3999.

    Article  Google Scholar 

  10. Franco LM, Krishnamurthy V, Bali D, et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis. 2005;28:153–162.

    Article  CAS  Google Scholar 

  11. Bianchi L. Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr. 1993;152:63–70.

    Article  Google Scholar 

  12. Limmer J, Fleig WE, Leupold D, et al. Hepatocellular carcinoma in type I glycogen storage disease. Hepatology. 1988;8:531–537.

    Article  CAS  Google Scholar 

  13. Kishnani PS, Chuang TP, Bali D, et al. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. Hum Mol Genet. 2009;18:4781–4790.

    Article  CAS  Google Scholar 

  14. Kakar S, Burgart LJ, Batts KP, et al. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol. 2005;18:1417–1423.

    Article  Google Scholar 

  15. Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–748.

    Article  CAS  Google Scholar 

  16. Bioulac-Sage P, Sempoux C, Balabaud C. Hepatocellular adenoma: classification, variants and clinical relevance. Semin Diagn Pathol. 2017;34:112–125.

    Article  Google Scholar 

  17. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–524.

    Article  CAS  Google Scholar 

  18. Wang DQ, Carreras CT, Fiske LM, et al. Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib. Genet Med. 2012;14:795–799.

    Article  CAS  Google Scholar 

  19. Gleeson D, Newbould MJ, Taylor P, et al. Androgen associated hepatocellular carcinoma with an aggressive course. Gut. 1991;32:1084–1086.

    Article  CAS  Google Scholar 

  20. Johnson FL, Feagler JR, Lerner KG, et al. Association of androgenic anabolic steroid therapy with development of hepatocellular carcinoma. Lancet. 1972;16:1273–1276.

    Article  Google Scholar 

  21. Farrell GC, Joshua DE, Uren RF, et al. Androgen-induced hepatoma. Lancet. 1975;22:430–432.

    Article  Google Scholar 

  22. Solbach P, Potthoff A, Raatschen HJ, et al. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterol. 2015;15:60. https://doi.org/10.1186/s12876-015-0288-0.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Gorayski P, Thompson CH, Subhash HS, et al. Hepatocellular carcinoma associated with recreational anabolic steroid use. Br J Sports Med. 2008;42:74–75.

    Article  CAS  Google Scholar 

  24. Socas L, Zumbado M, Perez-Luzardo O, et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med. 2005;39:e27.

    Article  CAS  Google Scholar 

  25. Hardt A, Stippel D, Odenthal M, et al. Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report. Case Rep Pathol. 2012;2012:195607. https://doi.org/10.1155/2012/195607. Epub 2012 Jul 5.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Forman D, Vincent TJ, Doll R, et al. Oral contraceptives and hepatocellular carcinoma. Br Med J (Clin Res Ed). 1986;292:1355–1357.

    Article  Google Scholar 

  27. Forman D, Vincent TJ, Doll R. Cancer of the liver and the use of oral contraceptives. Br Med J (Clin Res Ed).1986; 292: 1357–61.

    Article  CAS  Google Scholar 

  28. Smalley SR, Moertel CG, Hilton JF, et al. Hepatoma in the noncirrhotic liver. Cancer. 1988;62:1414–1424.

    Article  CAS  Google Scholar 

  29. Brancatelli G, Federle MP, Grazioli L, et al. Hepatocellular carcinoma in noncirrhotic liver: CT, clinical and pathologic findings in 39 U.S. residents. Radiology. 2002;222:89–94.

    Article  Google Scholar 

  30. Sechi A, Deroma L, Lapolla A, et al. Fertility and pregnancy in women affected by glycogen storage disease type I: results of a multicenter Italian study. J Inherit Metab Dis. 2013;36:83–89.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christina Ling.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ling, C., Khalid, S., Martin, D. et al. HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough. Dig Dis Sci 64, 3440–3445 (2019). https://doi.org/10.1007/s10620-019-05920-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-019-05920-z

Keywords

Navigation